Nj State Employees Deferred Compensation Plan Alkermes Plc. Transaction History

Nj State Employees Deferred Compensation Plan

  • $800 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 06, 2018
SELL
$47.69 - $55.39 $476,900 - $553,900
-10,000 Closed
0 $0
Q3 2017

Oct 30, 2017
BUY
$49.16 - $54.45 $491,599 - $544,500
10,000
10,000 $508,000

Others Institutions Holding ALKS

# of Institutions
377
Shares Held
166M
Call Options Held
231K
Put Options Held
158K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.42B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Nj State Employees Deferred Compensation Plan Portfolio

Follow Nj State Employees Deferred Compensation Plan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email